SEC 13F Intelligence

Managers / Q3 2020 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$232M
Q3 2020
Positions
38
Filings on Record
30
2019–present window
Filed
Nov 13, 2020
original filing

Summary

Sivik Global Healthcare LLC reported $232M in U.S.-listed holdings across 38 positions for Q3 2020.

Its largest position, ABT, represents 4.2% of the portfolio.

Compared with Q2 2020, the fund opened 12 new positions and exited 25.

Portfolio Metrics

Turnover
+38.2%
vs prior filed quarter
Top-10 Concentration
+36.6%
share of reported value
Largest Position
+4.2%
Abbott Labs
New / Exited
12 / 25
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 93.6%Other: 6.4%
  • Common Stock · 93.6% · $218M
  • Other · 6.4% · $15M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
LLYELI LILLY & CONEW+55.0K55.0K+$8M$8M
CATALENT INCNEW+92.5K92.5K+$8M$8M
UHSUNIV HEALTH SVCNEW+65.0K65.0K+$7M$7M
UNHUNITEDHEALTH GRPNEW+22.0K22.0K+$7M$7M
BAXBAXTER INTERNATIONAL INC.NEW+85.0K85.0K+$7M$7M
BSXBOSTON SCIENTIFIC CORPORATIONNEW+170.0K170.0K+$6M$6M
CHRLS RIVER LABSNEW+25.0K25.0K+$6M$6M
IQVIQVIA HOLDINGS INCNEW+30.0K30.0K+$5M$5M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2020

38 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ABTABBOTT LABShistory →Cash Securities4.21%$10M90.0K
2DHRDANAHER CORPhistory →Cash Securities4.17%$10M45.0K
3JNJJOHNSON&JOHNSONhistory →Cash Securities3.84%$9M60.0K
4TMOTHERMO FISHER SCIENTIFIC INC.history →Cash Securities3.80%$9M20.0K
5HUMHUMANA INC.history →Cash Securities3.56%$8M20.0K
6MOHMOLINA HLTHCAREhistory →Cash Securities3.54%$8M45.0K
7LLYELI LILLY & COhistory →Cash Securities3.50%$8M55.0K
8CATALENT INCCash Securities3.41%$8M92.5K
9MCKMCKESSON CORPhistory →Cash Securities3.36%$8M52.5K
10LAB CP AMERCash Securities3.24%$8M40.0K
11ZBHZIMMER BIOMET HOLDINGS INChistory →Cash Securities3.22%$7M55.0K
12HCAHCA HEALTHCARE INChistory →Cash Securities3.22%$7M60.0K
13PPD INCCash Securities3.18%$7M200.0K
14CNCCENTENE CORPhistory →Cash Securities3.14%$7M125.0K
15MDTMEDTRONIC PLC COM STKhistory →Cash Securities3.13%$7M70.0K
16UHSUNIV HEALTH SVChistory →Cash Securities2.99%$7M65.0K
17UNHUNITEDHEALTH GRPhistory →Cash Securities2.95%$7M22.0K
18BAXBAXTER INTERNATIONAL INC.history →Cash Securities2.94%$7M85.0K
19BSXBOSTON SCIENTIFIC CORPORATIONhistory →Cash Securities2.79%$6M170.0K
20SYKSTRYKER CORPhistory →Cash Securities2.69%$6M30.0K
21CORAMERISOURCE BERGEN CORPhistory →Cash Securities2.50%$6M60.0K
22DGXQUEST DIAGhistory →Cash Securities2.46%$6M50.0K
23CHRLS RIVER LABSCash Securities2.43%$6M25.0K
24AVTRAVANTOR INChistory →Cash Securities2.42%$6M250.0K
25REGNREGENERON PHARMACEUTICALS INChistory →Cash Securities2.41%$6M10.0K
26MRKMERCK & COhistory →Cash Securities2.14%$5M60.0K
27BMRNBIOMARIN PHARMhistory →Cash Securities2.13%$5M65.0K
28IQVIQVIA HOLDINGS INChistory →Cash Securities2.03%$5M30.0K
29EHCENCOMPASS HEALTH CORPhistory →Cash Securities1.82%$4M65.0K
30GHGUARDANT HEALTH INChistory →Cash Securities1.68%$4M35.0K
31BIOBIO-RAD LABS Ahistory →Cash Securities1.66%$4M7.5K
32BDXBECTON DICKINSON COhistory →Cash Securities1.60%$4M16.0K
33LHC GROUP LLCCash Securities1.60%$4M17.5K
34AMEDAMEDISYS INChistory →Cash Securities1.53%$4M15.0K
35BIIBBIOGEN INChistory →Cash Securities1.46%$3M12.0K
36ACHOWENS & MINORhistory →Cash Securities1.35%$3M125.0K
37NUVASIVECash Securities0.94%$2M45.1K
38S24SELECT MEDICAL HOLDINGS CORPCash Securities0.94%$2M105.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.